MANFREDINI, Rossella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.980
EU - Europa 6.073
AS - Asia 2.602
SA - Sud America 106
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 14
Totale 20.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.921
GB - Regno Unito 2.137
IT - Italia 1.299
SE - Svezia 861
SG - Singapore 753
CN - Cina 682
HK - Hong Kong 612
DE - Germania 381
RU - Federazione Russa 302
UA - Ucraina 227
FR - Francia 224
TR - Turchia 214
FI - Finlandia 187
BG - Bulgaria 117
ID - Indonesia 99
BR - Brasile 85
IN - India 68
SI - Slovenia 65
BE - Belgio 48
CA - Canada 46
IE - Irlanda 38
NL - Olanda 35
VN - Vietnam 33
IR - Iran 28
CZ - Repubblica Ceca 25
PL - Polonia 25
LT - Lituania 23
AU - Australia 20
JP - Giappone 18
TW - Taiwan 16
MY - Malesia 14
PK - Pakistan 14
CH - Svizzera 13
EU - Europa 13
KR - Corea 12
QA - Qatar 12
ES - Italia 11
AT - Austria 10
PT - Portogallo 10
KE - Kenya 7
MX - Messico 7
AR - Argentina 6
CO - Colombia 6
CL - Cile 5
LU - Lussemburgo 5
NO - Norvegia 5
PH - Filippine 5
RO - Romania 5
HU - Ungheria 4
IQ - Iraq 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
IL - Israele 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AL - Albania 2
BD - Bangladesh 2
BZ - Belize 2
EC - Ecuador 2
GR - Grecia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
EE - Estonia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
Totale 20.814
Salva come PNG Salva come JPEG
Città #
Southend 1.849
Fairfield 1.588
Santa Clara 1.454
Chandler 1.015
Woodbridge 978
Ashburn 832
Houston 719
Seattle 609
Hong Kong 602
Ann Arbor 554
Singapore 544
Cambridge 527
Nyköping 514
Wilmington 509
Jacksonville 432
Dearborn 399
Modena 287
Beijing 175
San Diego 163
Izmir 125
Princeton 123
Sofia 117
Helsinki 115
Jakarta 99
New York 91
Eugene 86
London 78
Moscow 78
Fremont 72
Milan 72
Bologna 69
Des Moines 62
Shanghai 62
Bremen 52
Reggio Emilia 46
Redwood City 44
Brussels 43
Falls Church 43
Shenzhen 38
Dublin 34
Rome 34
Dong Ket 31
Boardman 27
Munich 25
Sant'Ilario d'Enza 25
Parma 23
Frankfurt am Main 21
Los Angeles 21
Ottawa 21
Palermo 20
Brno 19
Hefei 19
Nuremberg 19
Paris 18
Phoenix 18
Toronto 18
Monmouth Junction 17
San Mateo 17
Florence 16
Hounslow 16
Kraków 16
Norwalk 16
Verona 15
Turin 14
Chiswick 13
Guangzhou 13
Doha 12
Grafing 12
Chicago 11
Jinan 11
Segrate 11
Augusta 10
Formigine 10
Nanjing 10
São Paulo 10
Kunming 9
Perugia 9
Ardabil 8
Auburn Hills 8
Hyderabad 8
Imola 8
Marano sul Panaro 8
Zurich 8
Dallas 7
Fuzhou 7
Indiana 7
Kilburn 7
Padova 7
Acton 6
Bangalore 6
Belo Horizonte 6
Bergamo 6
Ferrara 6
Islington 6
Kish 6
Mountain View 6
Naples 6
Napoli 6
Romainville 6
Saint Petersburg 6
Totale 16.081
Salva come PNG Salva come JPEG
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 406
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 308
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 300
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 288
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 280
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 278
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 276
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 272
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 267
Genomic landscape of megakaryopoiesis and platelet function defects 260
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 260
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 253
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 251
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 251
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 251
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 250
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 247
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 244
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 243
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 242
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 238
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 237
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 237
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 237
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 236
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 232
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 231
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 229
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 226
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 224
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 220
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 217
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 216
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 216
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 215
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 214
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 212
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 211
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 210
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 208
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 207
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 204
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 202
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 200
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 199
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 198
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 193
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 192
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 189
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 188
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 186
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 185
Terminal differentiation 184
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 183
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 182
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 181
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 180
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 179
Mutations and prognosis in primary myelofibrosis 179
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 177
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 169
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 166
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 166
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 165
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 162
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 162
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 160
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 159
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 159
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 159
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 152
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 151
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 147
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 145
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 144
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 143
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 142
Antisense strategies in leukemias 141
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 133
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 132
Isolation and characterization of murine liver resident stem cell 129
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 127
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 126
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 126
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 125
Cultured Normal Human Keratinocytes Secrete Stem-Cell Factor And Express C-Kit Receptor 123
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 123
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 121
miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes 117
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 117
Silencing CD34 antigen in human hematopoietic stem cells 115
MITOCHONDRIAL-DNA DELETION IN A PATIENT WITH PROGRESSIVE OPHTHALMOPLEGIA 113
Magnesium favors the capacity of vitamin d3 to induce the monocyte differentiation of u937 cells 113
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 111
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cells.. 110
Characterization of new ATM deletion associated with hereditary breast cancer 109
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 106
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 100
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 99
Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity 86
Totale 19.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.774 0 0 0 0 0 0 616 387 305 134 171 161
2020/20213.188 290 196 236 304 289 249 214 341 175 429 269 196
2021/20222.630 136 228 299 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20253.400 178 65 120 395 1.226 933 483 0 0 0 0 0
Totale 21.045